Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists
Condition: Non-Valvular Atrial Fibrillation Interventions: Drug: Rivaroxaban (Xarelto, BAY-597939); Drug: VKAs Sponsors: Bayer; Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2020 Category: Research Source Type: clinical trials